Entero Therapeutics Inc (ENTO)
0.4597
-0.17
(-27.03%)
USD |
NASDAQ |
Nov 14, 13:01
Entero Therapeutics Enterprise Value: 64.19M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 64.19M |
| November 12, 2024 | 64.14M |
| November 11, 2024 | 64.22M |
| November 08, 2024 | 64.47M |
| November 07, 2024 | 64.33M |
| November 06, 2024 | 64.43M |
| November 05, 2024 | 64.59M |
| November 04, 2024 | 64.40M |
| November 01, 2024 | 64.47M |
| October 31, 2024 | 64.24M |
| October 30, 2024 | 64.10M |
| October 29, 2024 | 64.05M |
| October 28, 2024 | 63.95M |
| October 25, 2024 | 64.20M |
| October 24, 2024 | 64.45M |
| October 23, 2024 | 64.07M |
| October 22, 2024 | 64.13M |
| October 21, 2024 | 64.43M |
| October 18, 2024 | 64.71M |
| October 17, 2024 | 64.65M |
| October 16, 2024 | 63.86M |
| October 15, 2024 | 62.66M |
| October 14, 2024 | 62.68M |
| October 11, 2024 | 62.73M |
| October 10, 2024 | 62.50M |
| Date | Value |
|---|---|
| October 09, 2024 | 62.56M |
| October 08, 2024 | 62.56M |
| October 07, 2024 | 62.89M |
| October 04, 2024 | 63.15M |
| October 03, 2024 | 62.33M |
| October 02, 2024 | 62.26M |
| October 01, 2024 | 62.24M |
| September 30, 2024 | 62.32M |
| September 27, 2024 | 62.31M |
| September 26, 2024 | 62.33M |
| September 25, 2024 | 62.25M |
| September 24, 2024 | 62.22M |
| September 23, 2024 | 62.21M |
| September 20, 2024 | 62.27M |
| September 19, 2024 | 62.30M |
| September 18, 2024 | 62.30M |
| September 17, 2024 | 62.34M |
| September 16, 2024 | 62.39M |
| September 13, 2024 | 62.33M |
| September 12, 2024 | 62.27M |
| September 11, 2024 | 62.63M |
| September 10, 2024 | 62.54M |
| September 09, 2024 | 62.50M |
| September 06, 2024 | 62.48M |
| September 05, 2024 | 62.51M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-0.9703M
Minimum
Dec 18 2023
114.44M
Maximum
Mar 16 2021
24.85M
Average
14.48M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.432M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 6.814M |
| Theriva Biologics Inc | -13.26M |
| Oragenics Inc | 2.142M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.808M |
| Total Expenses (Quarterly) | 3.426M |
| EPS Diluted (Quarterly) | -3.86 |
| Earnings Yield | -3.34K% |